Generally, no. UK health insurers treat weight management as a chronic, lifestyle-related condition, so weight-loss drugs such as Wegovy and Mounjaro and bariatric surgery are almost always excluded. Private prescriptions run roughly £120–£250 a month self-pay. Conditions caused or worsened by weight — joint damage, sleep apnoea — are covered if they arise after you join.
- ✓Weight-loss injections and bariatric surgery are excluded by almost every UK health insurance policy.
- ✓Self-pay GLP-1 prescriptions typically cost £120–£250 a month through regulated online pharmacies.
- ✓Related new conditions — joint pain, sleep apnoea — are still covered on a normal policy.
Why insurers don't cover weight-loss treatment
Private medical insurance is built to cover acute conditions — things that appear, get treated, and resolve. Insurers classify weight management as chronic and lifestyle-related, which places it outside cover in the same way as diabetes management or blood-pressure medication. That classification applies whether the treatment is a GLP-1 injection, a supervised diet programme or bariatric surgery.
The scale of demand makes the exclusion feel newly unfair, but it isn't new policy. Insurers have excluded weight-control treatment for decades — what's changed is that effective medication now exists, so the exclusion suddenly matters to millions of people. A few insurers are experimenting with weight-management support inside workplace wellbeing schemes, and that's the direction worth watching: if GLP-1s keep proving they reduce long-term claims for joint, cardiac and metabolic conditions, the commercial logic of blanket exclusion will come under pressure. For now, though, plan on the basis that treatment itself is yours to fund.
What weight-loss treatment costs privately
| Route | Typical self-pay cost | Notes |
|---|---|---|
| GLP-1 injections (Wegovy, Mounjaro) | £120–£250/month | Regulated online pharmacies; ongoing cost while treatment continues |
| Private weight-management clinic | £200–£500 initial, then monthly | Medical supervision plus prescription |
| Gastric band | £5,000–£8,000 | Day-case or one-night stay |
| Gastric sleeve | £9,000–£12,000 | The most common bariatric operation |
| Gastric bypass | £10,000–£15,000 | Larger operation, longer recovery |
Prices vary by provider and region. For medication, factor in that the cost is open-ended — stopping treatment typically means weight returns, so budget for years rather than months.
The NHS routes in 2026
The NHS does fund weight-loss treatment — with criteria. GLP-1 medication is available through specialist weight-management services for people meeting BMI and related-condition thresholds, and bariatric surgery is funded for more severe cases, usually after structured programmes have been tried. Waits for specialist services vary widely by area.
Eligibility broadly follows clinical guidance: GLP-1 prescribing is aimed at people with a BMI over set thresholds (lower where weight-related conditions such as type 2 diabetes, high blood pressure or sleep apnoea are present), and access runs through specialist services rather than routine GP prescribing. The practical constraint is capacity — specialist weight-management services have some of the most variable waits in the system, from weeks in some areas to a year or more in others.
If you are considering going private for speed, compare the full multi-year cost of self-pay medication against the NHS route before committing.
Cover for everything else, from £38 a month
What your policy still covers
Exclusion of weight-loss treatment doesn't touch the rest of your cover. Conditions that arise after you join are covered in the normal way, even where weight is a contributing factor:
- Joint problems. Knee and hip damage — diagnosis, physio and surgery are covered as new musculoskeletal conditions.
- Sleep apnoea. Investigation and diagnosis of new symptoms is typically covered.
- Gallbladder disease. More common after rapid weight loss — covered as a new acute condition.
- Skin removal after major weight loss. Almost never covered — it is classed as cosmetic.
One caveat: conditions you already had when you joined are pre-existing, whatever their cause. Our pre-existing conditions guide explains how the look-back rules work.
Declaring weight and GLP-1 use when you apply
Two application questions trip people up. First, insurers may ask height and weight — answer accurately; BMI rarely blocks cover on standard policies, and misstating it risks far more than it saves. Second, list any medication you take, including private GLP-1 prescriptions. Taking Wegovy or Mounjaro is not itself a problem, but the conditions behind it can shape underwriting: existing joint pain, sleep apnoea or pre-diabetes would be assessed as pre-existing in the normal way.
Should you still get health insurance?
If your main goal is funding weight-loss medication, insurance is the wrong tool — self-pay or the NHS route will serve you better. But if you are managing your weight and want fast access to diagnosis and treatment for everything else — the joint pain, the gallstones, the sleep clinic — cover priced from around £38 a month for a healthy 30-year-old does exactly that job.
Frequently asked questions
Does any UK health insurer cover Wegovy or Mounjaro?
As a rule, no. Weight-loss medication is excluded as treatment for a chronic, lifestyle-related condition across mainstream UK insurers. A small number of workplace wellbeing schemes subsidise weight-management programmes, but that sits outside the insurance policy itself. Always check the current policy wording — positions can change.
How much does Mounjaro cost privately in the UK?
Typically £120–£250 a month depending on dose and pharmacy, through regulated online providers. The cost is ongoing for as long as treatment continues, so the realistic comparison is an annual cost of roughly £1,500–£3,000 rather than a one-off price.
Is bariatric surgery ever covered by health insurance?
Almost never — gastric bands, sleeves and bypasses are excluded as weight-control treatment. Self-pay prices range from about £5,000 for a band to £15,000 for a bypass. The NHS funds bariatric surgery for people meeting clinical criteria, usually after structured weight-management programmes.
Will insurance cover my knee pain if it's caused by my weight?
Yes, if the knee problem is new and arose after you joined. Insurers cover the condition being treated, not the contributing factors — so diagnosis, physiotherapy and surgery for a new joint problem are covered in the normal way.
Does health insurance cover skin removal after losing weight?
No — excess skin removal is classed as cosmetic surgery and excluded, even after dramatic, medically supervised weight loss. Some people fund it self-pay; abdominoplasty typically costs £6,000–£9,000 privately.
Can I get weight-loss injections on the NHS instead?
Yes, if you meet the criteria — NHS specialist weight-management services can prescribe GLP-1 medication based on BMI thresholds and related conditions, at standard NHS prescription cost. Access and waiting times vary significantly by area, which is the honest trade-off against going private.
Will taking Wegovy affect my health insurance application?
You must declare it like any medication when asked. Taking a GLP-1 doesn't usually prevent cover, but weight-related conditions you already have would be treated as pre-existing under normal underwriting rules. Never omit it — non-disclosure risks claims being declined.
Does losing weight lower my health insurance premium?
Not directly for most insurers — premiums are priced on age, postcode and cover rather than BMI for standard policies. Vitality-style programmes are the exception: engagement with health goals can earn premium discounts over time.
Do Vitality or other insurers reward weight loss with lower premiums?
Indirectly, in one case. Vitality's programme discounts premiums for measured healthy activity, which can include weight-management engagement — but that's a rewards mechanism, not cover for treatment. No mainstream UK insurer currently pays for weight-loss medication or surgery as a policy benefit, whatever your engagement level.
Is weight-loss medication cover likely to change in future?
Possibly, and it's worth re-checking at each renewal. As evidence builds that GLP-1 treatment reduces long-term joint, cardiac and diabetes claims, insurers have a commercial incentive to fund it. Workplace wellbeing pilots are already appearing. Any change would arrive insurer by insurer, which is exactly the kind of shift a whole-of-market comparison catches.